Dear Member, welcome to PEGS BOSTON 2018
April 30 – May 4
Location: Seaport World Trade Center, Boston MA

PEGS_Boston

Nanotechnology in medicine, or nanomedicine, is a relatively new field. The use of nanoparticles to diagnose and treat diseases as well as future potential to make repairs at the cellular level has spawned great interest among the pharma and biopharma industries.

CHI’s inaugural Nanotechnology in Medicine conference seeks to bring together the interdisciplinary researchers from chemistry, engineering, biology and medicine together to explore the use of nanomaterials including nanoparticles, nanodevices, nanorobots, that will revolutionize drug delivery, diagnostics and therapeutics applications.

Link to PEGS Summit Join us!

SECURE YOUR SEAT NOW

Conference At-A-Glance

• NANOSENSING AND IMAGING KEYNOTE PRESENTATION: Development of Uniform-Sized Inorganic Nanoparticles for Clinical Applications
Taeghwan Hyeon, PhD, SNU Distinguished Professor, School of Chemical and Biological Engineering, Seoul National University

• Targeted Nanoparticles for Imaging, Drug Delivery and Biosensing
Paul Millner, PhD, Professor of Bionanotechnology, School of Biomedical Sciences, University of Leeds

• Assemble Nanoparticles in vivo for Cancer Imaging and Treatment
Jianghong Rao, PhD, Professor, Radiology and Chemistry (courtesy), Molecular Imaging Program, Cancer Biology and Biophysics Programs, Stanford University

• Biomimetic Nanotechnology Enhances Surface Detection of Circulating Tumor Cells in Peripheral Blood from Head and Neck Cancer Patients
Seungpyo Hong, PhD, Professor, Pharmaceutics, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison

• Digital Resolution Biomolecule Sensing by Photonic Resonator Absorption Microscopy (PRAM) with Plasmonic Nanoparticle Tags
Brian T. Cunningham, PhD, Willett Professor of Engineering, Director, Micro and Nanotech Lab, Electrical and Computer Engineering, University of Illinois at Urbana -Champaign

• NANOTHERAPEUTICS Development of Novel Antibody Directed Nanotherapeutics for the Treatment of Solid Tumors
Daryl Drummond, PhD, Head of Research, Merrimack Pharmaceuticals

• Enabling and Expanding the Use of Microbial-Derived Biologics through the Use of Tolerogenic Nanoparticles
Kei Kishimoto, PhD, CSO, Selecta Biosciences

• Safe and Effective Nanomedicines for Cancer and Inflammatory Diseases
Hayat Onyuksel, PhD, Professor, Biopharmaceutical Sciences, University of Illinois

• A Modular Platform for Targeted RNAi Therapeutics Using Biologically-Lipidated Antibodies
Itai Benhar, PhD, Professor, Molecular Microbiology and Biotechnology, The George S. Wise Faculty of Life Sciences, Tel Aviv University

• Smart, Multifunctional Liposomal Nanoformulation for Treating Fabry and Other Rare Diseases
Jose Luis Corchero Nieto, PhD, Senior Scientist, Nanobiotechnology Group, CIBER-BBN, Institute of Biotechnology and Biomedicine, Universitat Autonoma de Barcelona

• Targeted Ultrasmall Silica Nanoparticles as Next-Generation Treatment Tools for Drug Delivery
Michelle Bradbury, MD, PhD, Director, Intraoperative Imaging, Radiology, Memorial Sloan Kettering Cancer Center

• NANOCARRIERS FOR DELIVERY Nanoemulsion Technology for Intranasal Immunization Facilitates Vaccine Uptake by Antigen Presenting Cells at Mucosal Tissues, Induces Innate Immunity, and Enhances Mucosal Immunity
Ali Fattom, PhD, Senior Vice President, Vaccine R&D, NanoBio Corp.

• Designing Nanoparticles to Actively and Specifically Penetrate Solid Tumors
Jan E. Schnitzer, MD, Director, Professor of Cellular & Molecular Biology, Proteogenomics Research Institute for Systems Medicine (PRISM)

• Synthetic mRNA Nanocarriers for the in situ Programming of Disease-Specific T Cells
Matthias Stephan, MD, PhD, Associate Member, Fred Hutchinson Cancer Research Center, Associate Professor, University of Washington

• Bioresponsive Nanotechnologies for Systemic RNA Delivery to TumorsJinjun Shi, PhD, Assistant Professor, Center for Nanomedicine, Brigham and Women’s Hospital, Harvard Medical School

Nanotechnology’s impact on society is going to be similar to the invention of electricity.

“Nanotechnology: The New Economy” conference will gather highly skilled professionals in the area. Scientists, politicians, economists will discuss the various applications of the technology, the consequente reshaping of the economic and social systems and how much it will change our daily life.

INL SUMMIT 2017 will take place on October 19th-20th. This is a one-of-a-kind event in the Iberian territory. It will be a great opportunity to discuss Nanotechnology amongst peers, to know more about this science, to network or to enrich your overall knowledge.

Link to INL SUMMIT 2017

Join us!

SECURE YOUR SEAT NOW- Link to tickets

Pilot plant for testing of nanopharmaceuticals

Dear Member,

Spinverse is working on an EU funded project called Nanopilot, which is coordinated by Cidetec in Spain. The aim of the project is to set up a pilot plant for the cost-efficient production of polymer-based nanopharmaceuticals in small GMP batches, used e.g. for early clinical trials (download PDF HERE).

During the project, siRNA-based nanopharmaceuticals, HIV nanovaccine and hyaluronan-based spheres for drug delivery will be produced at the pilot plant. At the end of the project (around 2017-2018) the aim is to expand the pilot plant offering also to other users and other kinds of (polymeric) nanopharmaceuticals. Spinverse role in the project is to gather information and to develop the services and assess the business potential of the project, and therefore we need to reach out to potential collaborators in order to hear their needs and opinions.

More about us: Spinverse is a Finnish consultant company within open innovation. The company has been founded 2004 and today it employs 50 people. We help companies and universities to apply for public funding, to find the right partners, and to coordinate the projects.

 

 

 

 

Dear Member

The sixth edition of applications to the nanomedTAB is open until the 18th of September 2017. Selected projects will be invited to attend the next TAB-In Sessions, to be held on the 19th of October 2017, in Malaga (Spain), in the framework of the 12th ETPN Annual Event. Go to website www.etpn2017.eu

A remote Skype session, on another day, is also a possibility for people that aren’t able to participate in the event.

6th Round of applications for the NanomedTAB is open. Download application in PDF here.

 

CLINAM

European Foundation for Clinical Nanomedicine BASEL, SWITZERLAND

Join the CLINAM Summit in Basel May 8-10.

10th European and Global Conference and Exhibition for Clinical Nanomedicine & Targeted Medicine: Enabling Technologies for Personalized Medicine.

Download Info and registration in PDF, click here

The nanomedTAB – Nanomedicine Translation Advisory Board (www.nanomedtab.eu) is a free-of-charge mentoring program to assess,

advise and accelerate promising nanomedicine projects to the market, based on the diverse experience of outstanding industry experts. Go to website.

With a total of 52 applications from 16 countries in EU and beyond, half of them currently benefiting from coaching, nanomedTAB is helping these projects to get to commercial application faster and more reliably.

The fifth edition of applications is now open until the 24th of April 2017, to companies and public and private research entities. Applications can be submitted at http://nanomedtab.eu/?apply. Download PDF here.

Selected projects will be invited to attend the TAB-In Sessions, a series of face-to-face meetings with experts, to be held on the 31st of May 2017, in Gothenburg (Sweden), in the framework of the NanoMed North Annual Meeting 2017.

Enatrans

Welcome to Annual Meeting and International Focus Seminar 2017

TIME: Wednesday May 31, 10.00–16.00
PLACE: Chalmers University of Technology, Gothenburg
Room KB, Kemigården 4. Map? Click here

 

REGISTRATION  here

DOWNLOAD program here

BREAKFAST SEMINAR: Nanomedicine – how to accelerate translation from research to market
• 6 February 2017, Stockholm, 07:30-10:30

07:30 Breakfast is served

8:00-8:30 Key Note presentation
Anna Sandström, Director, Science Relations, AstraZeneca
• Future potential of nanomedicine in the Life Science sector

8:30-9:00 European initiatives to help accelerate translation from research to market
• ENATRANS – Enabling Nanomedicine Translation, Rui Sousa, ENATRANS
• Nanomedicine Translation Advisory Board, Pedro Silva, TAB Management Unit
• How to pitch?, TAB expert
• AceForm4.0 – European collaboration in the formulation area, Lovisa Ringstad, SP

9:00-10:00 PITCH session – Presentation of nanomedicine projects
• FORMAMP – Innovative nanoformulation of peptides, Helena Bysell, SP
• Stable and efficient formulation for amourphous drugs, Sara Frykstrand, Disruptive materials
• Nanoporous silica for advanced drug delivery, Paulina Paszkiewicz, Nanologica
• Cellevate – a nano fiber company, Maximilian Ottosson, Cellevate
• Nanoprobes as optotracers of bacterial biofilms, Ferdinand Choong, Swedish Medical Nanoscience Center, Karolinska Institutet
• Optotracers – now you can really see it!, Susanne Löffler, Ebba Biotech

10:00-10:30 Coffee and networking
The seminar is organized by SP Technical Research Institute of Sweden/RISE in collaboration with SwedNanoTech, ENATRANS and NanoMedNorth.

Venue SP, Drottning Kristinas väg 45, Stockholm. 500 m from subway station Tekniska Högskolan.
Date & Time Monday 6 February 2017, 07:30-10:30
No fee The seminar including breakfast is free of charge.
Questions – general Helena Bysell, SP, helena.bysell@sp.se
Questions – practical Annika Bergström, SP, annika.bergstrom@sp.se
Final date to register 31 January

REGISTER HERE

7990_logotyper-frukost-mindre

Vill du eller någon du känner ge din syn på riskbedömningar, reglering och innovationssatsningar i förhållande till nanoteknologi?


Som en del av ett forskningsprojekt om nanoteknolog
i finansierat av MISTRA (www.mistraenvironmentalnanosafety.org) kommer forskare från Göteborgs universitet att undersöka hur intressenter i det svenska samhället ser på nanomaterial och nanoteknologi.

Vi är intresserade av att få kontaktuppgifter
till personer inom ert företag eller organisation som skulle kunna besvara en kort webenkät med frågor om riskbedömningar, reglering och innovationssatsningar i förhållande till nanoteknologi.

Vill ni delta i studien kontakta simon.larsson@gu.se
så snart som möjligt. Simon kan även ge mer information om forskningsprojektet.
Nanotechnology and nanostructure with nanoparticles, atomic and molecular structure concept

A graphene scientist and NanoMed North member, Jie Sun, associate professor from Chalmers, is searching for people and/or organizations working with biochips.

For further discussions and potential collaboration please reply to jie.sun@chalmers.se

chalmers